Treatments being tested
Clinical trials open to people with bowel cancer
Every trial here is a live record from ClinicalTrials.gov, the public registry every trial must be listed on before it starts. Statuses are re-checked against the registry every day or two, because a list that says a closed trial is recruiting is worse than no list at all.
Listing a trial is not a recommendation, and this site has no connection to any of them. Whether a trial is right for you, and whether you would be eligible, is a conversation for your own oncology team.
What these filters mean
Genotype
These are the things that make a tumour unusual, so leave them alone unless one of them is yours. Nothing selected shows every trial. Wild-type and pMMR are the ordinary results and have no button of their own: they would match almost everybody, so they would narrow nothing. Selecting a mutation drops the trials that need the ordinary result instead â which is right, because those are the ones you could not join.
Which KRAS
Only relevant if your tumour is KRAS mutated. Your report will name the exact change, such as G12C or G12D; some newer drugs are built for one specific change and no other.
Each trial is tagged by reading its own eligibility criteria automatically, to make the list searchable. The tags summarise what the criteria mention — they are not a decision about whether you qualify, and where a tag and the criteria disagree, the criteria are right.
47 trials
Recruiting nowNot phased
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
Recruiting nowNot phased
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
Recruiting nowNot phased
Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research
Recruiting nowNot phased
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer
Recruiting nowNot phased
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Recruiting nowNot phased
Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision
Recruiting nowNot phased
Aerobic Exercise and Guided Imagery in Low Anterior Resection Syndrome
Recruiting nowNot phased
Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
Recruiting nowNot phased
Large Language Models Assist in Tumor MDT
Recruiting nowNot phased
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Recruiting nowNot phased
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
Recruiting nowNot phased
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Recruiting nowNot phased
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Recruiting nowNot phased
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy
Recruiting nowNot phased
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies